Last updated on June 2019

Individual Differences in Drug Response


Brief description of study

This study will evaluate the magnitude of individual differences that exist in human response to a blinded study medication.

Detailed Study Description

This study will assess a broad range of potential outcomes related to administration of a double-blinded, but FDA-approved study medication. Participants will be required to spend the night on a clinical research unit, located on the Johns Hopkins Bayview Medical Campus, for 4 consecutive nights (Monday - Friday). Participants will undergo daily sessions Tuesday - Friday. Tuesday sessions will consist of taking a study medication in the morning and afternoon, and completing a pain testing session after each study drug administration. Wednesday through Friday sessions will consist of taking a study drug in the morning and providing self-report ratings of drug effects and vital sign measurements (such as blood pressure, pulse) several times for a 6-hour period. The investigators will also collect saliva samples to assess physiological functioning, and will ask you to complete a computerized task to assess levels of functioning.

Clinical Study Identifier: NCT02360371

Find a site near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.